Equity
€64,482 ▼ 36.6%
VASCUMED paid out €82,353 in dividends. That is 182% of the 2025 profit.
VASCUMED
Lifetime
11 annual accounts with figures on one time axispeak €85,445 (2024)
€82,207▼ 3.8%
lowest -€15,459 (2018)
€45,150▲ 22.1%
peak €101,686 (2024)
€64,482▼ 36.6%
€191,006▼ 1.3%
Board1 name since 2014
1 director
Documentsfilings and deeds
22-04-20268 days before the deadline
2025micro format
Dividend €82,353Equity from €101,686 to €64,482
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 5,052 companies had the same profile as VASCUMED has now. Each dot stands for 13 companies, two years later.
95.8%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,052 companies, not a prediction for VASCUMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Change of role: , from manager to director
Director discharge: · Registered office clause: Avenue du Parc 122/RCH0, 1190 Forest · holds all the shares · General meeting of 16-03-2022 · Gazette deed
Registered-office move
Director in office: (manager) · General meeting of 01-07-2015 · Gazette deed
Incorporation
published on 23-09-2014 · Gazette deed
First establishment
Overwinningsstraat 11, Sint-Gillis (bij-Brussel)
Official details
Source: KBO- Status
- Active since 19-09-2014Normal situation
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.235.072.8121060 Sint-Gillis (bij-Brussel), since 19-09-2014
- Financial year end
- 30 September
- Peppol
- Not found in the Peppol Directory
Annual accounts to 30-09-2025
- ≈ €250,000estimated
- €255,488▼ 13.4%
- Filing
- Filed on 22-04-2026, 8 days before the end of the filing period
Insights on VASCUMED
VASCUMED files the micro format. That format states no turnover. The gross margin rose from €23,329 in 2015 to €82,207 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about VASCUMED
- What is the company number of VASCUMED?
- The company number of VASCUMED is 0562.827.355. The VAT number is the same number with BE in front: BE 0562.827.355.
- Where is VASCUMED based?
- The registered office is at Parklaan 122/RCH0, 1190 Forest.Company details
- What is the legal form of VASCUMED?
- VASCUMED is a private limited company (BV).
- When was VASCUMED founded?
- VASCUMED was founded on 19-09-2014.
- Is VASCUMED still active?
- Yes, VASCUMED is an active enterprise in the KBO register.
- What is the turnover of VASCUMED?
- The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €82,207 and 2,662 comparable companies of the same size. It probably lies between €160,000 and €430,000. It is a rough estimate. In financial year 2021 turnover was €138,675.Financials
- Is VASCUMED profitable?
- In financial year 2025, VASCUMED made a profit of €45,150.
- Where can I find the annual accounts of VASCUMED?
- VASCUMED filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of VASCUMED due?
- VASCUMED must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.